Table 3 Participant characteristics
Variable | Intervention group (n = 18) | Control group (n = 19) |
|---|---|---|
Age (in years); mean (SD) | 79 (3.57) | 80 (6.17) |
Gender (female); n (%) | 10 (56) | 10 (53) |
Income; n (%) | ||
≤ US $20,000 | - | 3 (16) |
US $20,001–50,000 | 6 (33) | 8 (42) |
US $50,001–70,000 | 3 (17) | 3 (16) |
US $70,001–100,000 | 3 (17) | 2 (11) |
100,001–150,000 | 3 (17) | - |
> US $150,000 | - | 1 (5) |
Private insurance (yes); n (%) | 1 (5.6) | 1 (5) |
BMQ general score; mean (SD) | 20.17 (3.31) | 21.37 (3.35) |
Range | 15.00, 28.00 | 16.00, 27.00 |
BMQ specific score; mean (SD) | 30.35 (4.83) | 31.47 (3.12) |
Range | 17.00, 38.00 | 26.00, 38.00 |
Charlson Comorbidity Index score; mean (SD) | ||
Range | 3.61 (2.64) 1.00, 9.00 | 2.95 (2.48) 0.00, 8.00 |
Number of prescribed medications; mean (SD) | ||
Range | 7.33 (1.78) 4.00, 10.00 | 8.26 (3.63) 5.00, 18.00 |